Elbit Medical Imaging parent Elron Electronic Industries announced Feb. 25 that it will sell its 37.3% stake in Elbit to Europe Israel for approximately $145 million. Haifa, Israel-based Elron Electronic is a high-tech holding company involved in defense
Elbit Medical Imaging parent Elron Electronic Industries announced Feb. 25 that it will sell its 37.3% stake in Elbit to Europe Israel for approximately $145 million. Haifa, Israel-based Elron Electronic is a high-tech holding company involved in defense electronics, communication, semiconductors, networking, software, and information technology. Europe Israel operates in three main areas: hotels, shopping and entertainment centers, and high-tech ventures. The deal is expected to close at the end of this month.
Elrons effort to sell Elbit comes while Elbit is in negotiations with its subsidiary Elscint for the purchase of Elscints remaining shares. In February, Elbit offered Elscint about $100 million (SCAN 3/3/99) for the shares. An independent committee of outside directors formed by Elscints board issued a statement March 2 expressing willingness to begin negotiations for the deal.
As it contemplates its own sale, Elbit, also of Haifa, this month announced that it has been served with notice of a second shareholder lawsuit, similar to one filed late last year (SCAN 11/25/98). The second class-action suit is based on a comparable claim filed in November in the name of all holders of Elbit stock warrants since 1994. It claims that since Elbit did not disclose that it was planning to sell the bulk of Elscints business before the warrants expired, the plaintiffs were prevented from benefiting from the stock increase that resulted from the sale announcements.
The second suit requests damages for claimants who sold warrants between Aug. 1 and and Aug. 31, 1998 for a lower price than they would have received if Elbit had made its sale negotiations for Elscint known. Elbit rejects the claim and will attempt to have it dropped.
European Society of Breast Imaging Issues Updated Breast Cancer Screening Recommendations
April 24th 2024One of the recommendations from the European Society of Breast Imaging (EUSOBI) is annual breast MRI exams starting at 25 years of age for women deemed to be at high risk for breast cancer.
Study Reveals Benefits of Photon-Counting CT for Assessing Acute Pulmonary Embolism
April 23rd 2024In comparison to energy-integrating detector CT for the workup of suspected acute pulmonary embolism, the use of photon-counting detector CT reduced radiation dosing by 48 percent, according to newly published research.